Article Details
Retrieved on: 2018-01-15 15:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Renaissance Technologies</b> LLC purchased a new stake in shares of CytRx in the first quarter valued at $264,000. Vanguard Group Inc. lifted its holdings in shares of CytRx by 53.9% in the second quarter. Vanguard Group Inc. now owns 4,823,123 shares of the biotechnology company's stock valued at ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here